[1]
|
Shine, E.E. and Crawford, J.M. (2021) Molecules from the Microbiome. Annual Review of Biochemistry, 90, 789-815.
https://doi.org/10.1146/annurev-biochem-080320-115307
|
[2]
|
Amato, K.R., Arrieta, M.C., Azad, M.B., Bailey, M.T., Broussard, J.L., Bruggeling, C.E., Claud, E.C., et al. (2021) The Human Gut Microbiome and Health Inequities. Proceedings of the National Academy of Sciences of the United States of America, 118, e2017947118. https://doi.org/10.1146/annurev-biochem-080320-115307
|
[3]
|
Kriss, M., Hazleton, K.Z., Nusbacher, N.M., Martin, C.G. and Lozupone, C.A. (2018) Low Diversity Gut Microbiota Dysbiosis: Drivers, Functional Implications and Recovery. Current Opinion in Microbiology, 44, 34-40.
https://doi.org/10.1016/j.mib.2018.07.003
|
[4]
|
Trebicka, J., Macnaughtan, J., Schnabl, B., Shawcross, D.L. and Bajaj, J.S. (2021) The Microbiota in Cirrhosis and Its Role in Hepatic Decompensation. Journal of Hepatology, 75, S67-S81. https://doi.org/10.1016/j.jhep.2020.11.013
|
[5]
|
Dabke, K., Hendrick, G. and Devkota, S. (2019) The Gut Microbiome and Metabolic Syndrome. Journal of Clinical Investigation, 129, 4050-4057. https://doi.org/10.1172/JCI129194
|
[6]
|
He, F. and Li, Y. (2020) Role of Gut Microbiota in the Development of Insulin Resistance and the Mechanism Underlying Polycystic Ovary Syndrome: A Review. Journal of Ovarian Research, 13, Article No. 73.
https://doi.org/10.1186/s13048-020-00670-3
|
[7]
|
Niewczas, M.A., Pavkov, M.E., Skupien, J., Smiles, A., Md Dom, Z.I., Wilson, J.M., Park, J., et al. (2019) A Signature of Circulating Inflammatory Proteins and Development of End-Stage Renal Disease in Diabetes. Nature Medicine, 25, 805-813. https://doi.org/10.1038/s41591-019-0415-5
|
[8]
|
Boughton, C.K., Tripyla, A., Hartnell, S., Daly, A., Herzig, D., Wilinska, M.E., Czerlau, C., et al. (2021) Fully Automated Closed-Loop Glucose Control Compared with Standard Insulin Therapy in Adults with Type 2 Diabetes Requiring Dialysis: An Open-Label, Randomized Crossover Trial. Nature Medicine, 27, 1471-1476.
https://doi.org/10.1038/s41591-021-01453-z
|
[9]
|
Papadopoulou-Marketou, N., Paschou, S.A., Marketos, N., Adamidi, S., Adamidis, S. and Kanaka-Gantenbein, C. (2018) Diabetic Nephropathy in Type 1 Diabetes. Minerva Medica, 109, 218-228.
https://doi.org/10.23736/S0026-4806.17.05496-9
|
[10]
|
Zhang, W.R. and Parikh, C.R. (2019) Biomarkers of Acute and Chronic Kidney Disease. Annual Review of Physiology, 81, 309-333. https://doi.org/10.1146/annurev-physiol-020518-114605
|
[11]
|
Lin, J.R., Wang, Z.T., Sun, J.J., Yang, Y.Y., Li, X.X., Wang, X.R., et al. (2022) Gut Microbiota and Diabetic Kidney Diseases: Pathogenesis and Therapeutic Perspectives. World Journal of Diabetes, 13, 308-318.
https://doi.org/10.4239/wjd.v13.i4.308
|
[12]
|
Maiti, A.K. (2021) Development of Biomarkers and Molecular Therapy Based on Inflammatory Genes in Diabetic Nephropathy. International Journal of Molecular Sciences, 22, Article No. 9985.
https://doi.org/10.3390/ijms22189985
|
[13]
|
Zhong, C., Dai, Z., Chai, L., Wu, L., Li, J., Guo, W., et al. (2021) The Change of Gut Microbiota-Derived Short-Chain Fatty Acids in Diabetic Kidney Disease. Journal of Clinical Laboratory Analysis, 35, e24062.
https://doi.org/10.1002/jcla.24062
|
[14]
|
Cai, K., Ma, Y., Cai, F., Huang, X., Xiao, L., Zhong, C., et al. (2022) Changes of Gut Microbiota in Diabetic Nephropathy and Its Effect on the Progression of Kidney Injury. Endocrine, 76, 294-303.
https://doi.org/10.1007/s12020-022-03002-1
|
[15]
|
Huang, W., Zhou, L., Guo, H., Xu, Y. and Xu, Y. (2019) The Role of Short-Chain Fatty Acids in Kidney Injury Induced by Gut-Derived Inflammatory Response. Metabolism, 68, 20-30. https://doi.org/10.1016/j.metabol.2016.11.006
|
[16]
|
Vaziri, N.D., Yuan, J. and Norris, K. (2023) Role of Urea in Intestinal Barrier Dysfunction and Disruption of Epithelial Tight Junction in Chronic Kidney Disease. American Journal of Nephrology, 37, 1-6.
https://doi.org/10.1159/000345969
|
[17]
|
Khan, I., Huang, Z., Liang, L., Li, N., Ali, Z., Ding, L., Hong, M., et al. (2021) Ammonia Stress Influences Intestinal Histomorphology, Immune Status and Microbiota of Chinese Striped-Neck Turtle (Mauremys sinensis). Ecotoxicology and Environmental Safety, 222, Article ID: 112471. https://doi.org/10.1016/j.ecoenv.2021.112471
|
[18]
|
Fernandez-Prado, R., Esteras, R., Perez-Gomez, M., Gracia-Iguacel, C., Gonzalez-Parra, E., Sanz, A., Ortiz, A., et al. (2019) Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease. Nutrients, 9, Article No. 489. https://doi.org/10.3390/nu9050489
|
[19]
|
Mao, Z.-H., Gao, Z.-X., Liu, D.-W., Liu, Z.-S., Wu, P., et al. (2023) Gut Microbiota and Its Metabolites-Molecular Mechanisms and Management Strategies in Diabetic Kidney Disease. Frontiers in Immunology, 14, Article ID: 1124704.
https://doi.org/10.3389/fimmu.2023.1124704
|
[20]
|
Heaney, L.M., Davies, O.G. and Selby, N.M. (2019) Gut Microbial Metabolites as Mediators of Renal Disease: Do Short-Chain Fatty Acids Offer Some Hope? Future Science OA, 5, FSO384. https://doi.org/10.4155/fsoa-2019-0013
|
[21]
|
Ramezani, A., Massy, Z.A., Meijers, B., Evenepoel, P., Vanholder, R. and Raj, D.S. (2020) Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. American Journal of Kidney Diseases, 67, 483-498.
https://doi.org/10.1053/j.ajkd.2015.09.027
|
[22]
|
Zhang, F., Qi, L., Feng, Q., Zhang, B., Li, X., Liu, C., Li, W., et al. (2021) HIPK2 Phosphorylates HDAC3 for NF-κB Acetylation to Ameliorate Colitis-Associated Colorectal Carcinoma and Sepsis. Proceedings of the National Academy of Sciences of the United States of America, 118, e2021798118. https://doi.org/10.1073/pnas.2021798118
|
[23]
|
Hu, X., Li, S., Fu, Y. and Zhang, N. (2019) Targeting Gut Microbiota as a Possible Therapy for Mastitis. European Journal of Clinical Microbiology & Infectious Diseases, 38, 1409-1423. https://doi.org/10.1007/s10096-019-03549-4
|
[24]
|
Benson, K., Cramer, S. and Galla, H.-J. (2023) Impedance-Based Cell Monitoring: Barrier Properties and Beyond. Fluids and Barriers of the CNS, 10, 5. https://doi.org/10.1186/2045-8118-10-5
|
[25]
|
Odijk, M., van der Meer, A.D., Levner, D., Kim, H.J., van der Helm, M.W., Segerink, L.I., Frimat, J.-P., Hamilton, G.A., Ingber, D.E. and van den Berg, A. (2019) Measuring Direct Current Trans-Epithelial Electrical Resistance in Organ-on- a-Chip Microsystems. Lab on a Chip, 15, 745-752. https://doi.org/10.1039/C4LC01219D
|
[26]
|
Groschwitz, K.R. and Hogan, S.P. (2019) Intestinal Barrier Function: Molecular Regulation and Disease Pathogenesis. Journal of Allergy and Clinical Immunology, 124, 3-20. https://doi.org/10.1016/j.jaci.2009.05.038
|
[27]
|
Gareau, M.G., Sherman, P.M. and Walker, W.A. (2020) Probiotics and the Gut Microbiota in Intestinal Health and Disease. Nature Reviews Gastroenterology & Hepatology, 7, 503-514. https://doi.org/10.1038/nrgastro.2010.117
|
[28]
|
LeBlanc, J.G., Milani, C., de Giori, G.S., Sesma, F., van Sinderen, D. and Ventura, M. (2023) Bacteria as Vitamin Suppliers to Their Host: A Gut Microbiota Perspective. Current Opinion in Biotechnology, 24, 160-168.
https://doi.org/10.1016/j.copbio.2012.08.005
|
[29]
|
Hagihara, M., Kuroki, Y., Ariyoshi, T., Higashi, S., Fukuda, K., Yamashita, R., Matsumoto, A., Mori, T., Mimura, K., Yamaguchi, M., et al. (2020) Clostridium Butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis. iScience, 23, Article ID: 100772.
https://doi.org/10.1016/j.isci.2019.100772
|
[30]
|
Nusrat, A., Turner, J.R. and Madara, J.L. (2020) Molecular Physiology and Pathophysiology of Tight Junctions. IV. Regulation of Tight Junctions by Extracellular Stimuli: Nutrients, Cytokines, and Immune Cells. The American Journal of Physiology-Gastrointestinal and Liver Physiology, 279, G851-G857.
https://doi.org/10.1152/ajpgi.2000.279.5.G851
|
[31]
|
Arrieta, M.C., Bistritz, L. and Meddings, J.B. (2018) Alterations in Intestinal Permeability. Gut, 55, 1512-1520.
https://doi.org/10.1136/gut.2005.085373
|
[32]
|
Mahmoodpoor, F., Rahbar Saadat, Y., Barzegari, A., Ardalan, M. and Zununi Vahed, S. (2017) The Impact of Gut Microbiota on Kidney Function and Pathogenesis. Biomedicine & Pharmacotherapy, 93, 412-419.
https://doi.org/10.1016/j.biopha.2017.06.066
|
[33]
|
de Andrade, L.S., Ramos, C.I. and Cuppari, L. (2019) The Cross-Talk between the Kidney and the Gut: Implications for Chronic Kidney Disease. Nutrire, 42, 2-14. https://doi.org/10.1186/s41110-017-0054-x
|
[34]
|
Soleimani, A., Zarrati Mojarrad, M., Bahmani, F., Taghizadeh, M., Ramezani, M., Tajabadi-Ebrahimi, M., Jafari, P., et al. (2021) Probiotic Supplementation in Diabetic Hemodialysis Patients Has Beneficial Metabolic Effects. Kidney International, 91, 435-442. https://doi.org/10.1016/j.kint.2016.09.040
|
[35]
|
Honda, K. and Littman, D.R. (2021) The Microbiota in Adaptive Immune Homeostasis and Disease. Nature, 535, 75-84. https://doi.org/10.1038/nature18848
|
[36]
|
Brown, E.M., Kenny, D.J. and Xavier, R.J. (2019) Gut Microbiota Regulation of T Cells during Inflammation and Autoimmunity. Annual Review of Immunology, 37, 599-624. https://doi.org/10.1146/annurev-immunol-042718-041841
|
[37]
|
Zheng, D., Liwinski, T. and Elinav, E. (2020) Interaction between Microbiota and Immunity in Health and Disease. Cell Research, 30, 492-506. https://doi.org/10.1038/s41422-020-0332-7
|
[38]
|
Cai, H.D., Su, S.L., Guo, J.M. and Duan, J.A. (2021) Effect of Salviae Miltiorrhizae Radix et Rhizoma on Diversity of Intestinal Flora in Diabetic Nephropathy Rats. China Journal of Chinese Materia Medica, 46, 426-435.
|
[39]
|
Li, Y., Su, X., Gao, Y., Lv, C., Gao, Z., Liu, Y., Wang, Y., et al. (2020) The Potential Role of the Gut Microbiota in Modulating Renal Function in Experimental Diabetic Nephropathy Murine Models Established in Same Environment. Biochimica et Biophysica Acta: Molecular Basis of Disease, 1866, Article ID: 165764.
https://doi.org/10.1016/j.bbadis.2020.165764
|
[40]
|
Yang, J., Kim, C.J., Go, Y.S., Lee, H.Y., Kim, M.G., Oh, S.W., Cho, W.Y., et al. (2020) Intestinal Microbiota Control Acute Kidney Injury Severity by Immune Modulation. Kidney International, 98, 932-946.
https://doi.org/10.1016/j.kint.2020.04.048
|
[41]
|
Nakade, Y., Iwata, Y., Furuichi, K., Mita, M., Hamase, K., Konno, R., Miyake, T., et al. (2018) Gut Microbiota-Derived D-Serine Protects against Acute Kidney Injury. JCI Insight, 3, e97957.
https://doi.org/10.1172/jci.insight.97957
|
[42]
|
Barrios, C., Beaumont, M., Pallister, T., Villar, J., Goodrich, J.K., Clark, A., Pascual, J., et al. (2022) Gut-Microbiota- Metabolite Axis in Early Renal Function Decline. PLOS ONE, 10, e0134311.
https://doi.org/10.1371/journal.pone.0134311
|
[43]
|
Jiang, S., Xie, S., Lv, D., Zhang, Y., Deng, J., Zeng, L. and Chen, Y. (2021) A Reduction in the Butyrate Producing Species Roseburia spp. and Faecalibacterium prausnitzii Is Associated with Chronic Kidney Disease Progression. Antonie van Leeuwenhoek, 109, 1389-1396. https://doi.org/10.1007/s10482-016-0737-y
|
[44]
|
Jiang, S., Xie, S., Lv, D., Wang, P., He, H., Zhang, T., Zhou, Y., et al. (2017) Alteration of the Gut Microbiota in Chinese Population with Chronic Kidney Disease. Scientific Reports, 7, Article No. 2870.
https://doi.org/10.1038/s41598-017-02989-2
|
[45]
|
Tao, S., Li, L., Li, L., Liu, Y., Ren, Q., Shi, M., Liu, J., et al. (2019) Understanding the Gut-Kidney Axis among Biopsy-Proven Diabetic Nephropathy, Type 2 Diabetes Mellitus and Healthy Controls: An Analysis of the Gut Microbiota Composition. Acta Diabetologica, 56, 581-592. https://doi.org/10.1007/s00592-019-01316-7
|
[46]
|
Stanford, J., Charlton, K., Stefoska-Needham, A., Ibrahim, R. and Lambert, K. (2020) The Gut Microbiota Profile of Adults with Kidney Disease and Kidney Stones: A Systematic Review of the Literature. BMC Nephrology, 21, Article No. 215. https://doi.org/10.1186/s12882-020-01805-w
|
[47]
|
Spychala, M.S., Venna, V.R., Jandzinski, M., Doran, S.J., Durgan, D.J., Ganesh, B.P., Ajami, N.J., et al. (2018) Age‐Related Changes in the Gut Microbiota Influence Systemic Inflammation and Stroke Outcome. Annals of Neurology, 84, 23-36. https://doi.org/10.1002/ana.25250
|
[48]
|
Salguero, M.V., Al-Obaide, M.A.I., Singh, R., Siepmann, T. and Vasylyeva, T.L. (2019) Dysbiosis of Gram-Negative Gut Microbiota and the Associated Serum Lipopolysaccharide Exacerbates Inflammation in Type 2 Diabetic Patients with Chronic Kidney Disease. Experimental and Therapeutic Medicine, 18, 3461-3469.
https://doi.org/10.3892/etm.2019.7943
|
[49]
|
Takeda, K. and Akira, S. (2022) TLR Signaling Pathways. Seminars in Immunology, 16, 3-9.
https://doi.org/10.1016/j.smim.2003.10.003
|
[50]
|
Mudaliar, H., Pollock, C. and Panchapakesan, U. (2022) Role of Toll-Like Receptors in Diabetic Nephropathy. Clinical Science (London), 126, 685-694. https://doi.org/10.1042/CS20130267
|
[51]
|
Mueller, N.T., Zhang, M., Juraschek, S.P., Miller, E.R. and Appel, L.J. (2020) Effects of High-Fiber Diets Enriched with Carbohydrate, Protein, or Unsaturated Fat on Circulating Short Chain Fatty Acids: Results from the OmniHeart Randomized Trial. The American Journal of Clinical Nutrition, 111, 545-554. https://doi.org/10.1093/ajcn/nqz322
|
[52]
|
Lin, M.Y., de Zoete, M.R., van Putten, J.P. and Strijbis, K. (2023) Redirection of Epithelial Immune Responses by Short-Chain Fatty Acids through Inhibition of Histone Deacetylases. Frontiers in Immunology, 6, Article No. 554.
https://doi.org/10.3389/fimmu.2015.00554
|
[53]
|
Aoki, R., Kamikado, K., Suda, W., Takii, H., Mikami, Y., Suganuma, N., Hattori, M. and Koga, Y. (2017) A Proliferative Probiotic Bifidobacterium Strain in the Gut Ameliorates Progression of Metabolic Disorders via Microbiota Modulation and Acetate Elevation. Scientific Reports, 7, Article No. 43522. https://doi.org/10.1038/srep43522
|
[54]
|
Huang, W., Guo, H.L., Deng, X., Zhu, T.T., Xiong, J.F., Xu, Y.H. and Xu, Y. (2017) Short-Chain Fatty Acids Inhibit Oxidative Stress and Inflammation in Mesangial Cells Induced by High Glucose and Lipopolysaccharide. Experimental and Clinical Endocrinology & Diabetes, 125, 98-105. https://doi.org/10.1055/s-0042-121493
|
[55]
|
Chen, T., Kim, C.Y., Kaur, A., Lamothe, L., Shaikh, M., Keshavarzian, A. and Hamaker, B.R. (2017) Dietary Fibre-Based SCFA Mixtures Promote Both Protection and Repair of Intestinal Epithelial Barrier Function in a Caco-2 Cell Model. Food & Function, 8, 1166-1173. https://doi.org/10.1039/C6FO01532H
|
[56]
|
Khan, S. and Jena, G. (2022) Sodium Butyrate, a HDAC Inhibitor Ameliorates eNOS, iNOS and TGF-β1-Induced Fibrogenesis, Apoptosis and DNA Damage in the Kidney of Juvenile Diabetic Rats. Food and Chemical Toxicology, 73, 127-139. https://doi.org/10.1016/j.fct.2014.08.010
|
[57]
|
Lu,C.C., Hu, Z.B., Wang, R., Hong, Z.H., Lu, J., Chen, P.P., Zhang, J.X., et al. (2020) Gut Microbiota Dysbiosis-Induced Activation of the Intrarenal Renin-Angiotensin System Is Involved in Kidney Injuries in Rat Diabetic Nephropathy. Acta Pharmacologica Sinica, 41, 1111-1118. https://doi.org/10.1038/s41401-019-0326-5
|
[58]
|
Tajiri, K. and Shimizu, Y. (2018) Branched-Chain Amino Acids in Liver Diseases. Translational Gastroenterology and Hepatology, 3, 47. https://doi.org/10.21037/tgh.2018.07.06
|
[59]
|
Feng, Y.-L., Cao, G., Chen, D.-Q., Vaziri, N.D., Chen, L., Zhang, J., et al. (2019) Microbiome-Metabolomics Reveals Gut Microbiota Associated with Glycine-Conjugated Metabolites and Polyamine Metabolism in Chronic Kidney Disease. Cellular and Molecular Life Sciences, 76, 4961-4978. https://doi.org/10.1007/s00018-019-03155-9
|
[60]
|
Nallu, A., Sharma, S., Ramezani, A., Muralidharan, J. and Raj, D. (2017) Gut Microbiome in Chronic Kidney Disease: Challenges and Opportunities. Translational Research, 179, 24-37. https://doi.org/10.1016/j.trsl.2016.04.007
|
[61]
|
Winther, S.A., Øllgaard, J.C., Tofte, N., Tarnow, L., Wang, Z., Ahluwalia, T.S., et al. (2019) Utility of Plasma Concentration of Trimethylamine n-Oxide in Predicting Cardiovascular and Renal Complications in Individuals with Type 1 Diabetes. Diabetes Care, 42, 1512-1520. https://doi.org/10.2337/dc19-0048
|
[62]
|
He, L., Yang, W., Yang, P., Zhang, X. and Zhang, A. (2022) Higher Serum Trimethylamine-n-Oxide Levels Are Associated with Increased Abdominal Aortic Calcification in Hemodialysis Patients. Renal Failure, 44, 2019-2027.
https://doi.org/10.1080/0886022X.2022.2145971
|
[63]
|
Kikuchi, K., Saigusa, D., Kanemitsu, Y., Matsumoto, Y., Thanai, P., Suzuki, N., et al. (2019) Gut Microbiome-Derived Phenyl Sulfate Contributes to Albuminuria in Diabetic Kidney Disease. Nature Communications, 10, Article No. 1835.
|
[64]
|
Molinaro, A., Lassen, P.B., Henricsson, M., Wu, H., Adriouch, S., Belda, E., et al. (2020) Imidazole Propionate Is Increased in Diabetes and Associated with Dietary Patterns and Altered Microbial Ecology. Nature Communications, 11, Article No. 5881.
|
[65]
|
Fernandes, R., Viana, S.D., Nunes, S. and Reis, F. (2019) Diabetic Gut Microbiota Dysbiosis as an Inflammaging and Immunosenescence Condition That Fosters Progression of Retinopathy and Nephropathy. Biochimica et Biophysica Acta: Molecular Basis of Disease, 1865, 1876-1897. https://doi.org/10.1016/j.bbadis.2018.09.032
|
[66]
|
Rossi, M., Campbell, K.L., Johnson, D.W., Stanton, T., Vesey, D.A., Coombes, J.S., et al. (2014) Protein-Bound Uremic Toxins, Inflammation and Oxidative Stress: A Cross-Sectional Study in Stage 3-4 Chronic Kidney Disease. Archives of Medical Research, 45, 309-317. https://doi.org/10.1016/j.arcmed.2014.04.002
|
[67]
|
Koppe, L., Fouque, D. and Soulage, C.O. (2018) Metabolic Abnormalities in Diabetes and Kidney Disease: Role of Uremic Toxins. Current Diabetes Reports, 18, Article No. 97. https://doi.org/10.1007/s11892-018-1064-7
|
[68]
|
Krukowski, H., Valkenburg, S., Madella, A.-M., Garssen, J., van Bergenhenegouwen, J., Overbeek, S.A., et al. (2022) Gut Microbiome Studies in CKD: Opportunities, Pitfalls and Therapeutic Potential. Nature Reviews Nephrology, 19, 87-101. https://doi.org/10.1038/s41581-022-00647-z
|